Medisca Inc. has voluntarily recalled approximately 161.6 grams (162 units) of Bimatoprost powder, a bulk pharmaceutical ingredient. The recall was initiated because the product was manufactured under conditions that deviated from current Good Manufacturing Practices (cGMP), which are the required safety standards for drug production. This bulk ingredient is typically used by pharmacies to create customized medications; while no injuries have been reported, the manufacturing issues mean the quality and safety of the product cannot be guaranteed.
The manufacturing deviations could lead to products that do not meet identity, strength, quality, or purity standards. Using a medication made from compromised ingredients may result in ineffective treatment or unexpected side effects for patients.
You have 2 options:
Bulk pharmaceutical ingredient manufactured in Plattsburgh, NY.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.